Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review
Year: 2018
Type: article
Source: Clinical Science
DOI: 10.1042/cs20171299
Institutions: Glasgow Royal Infirmary, University of Glasgow
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, type 2 diabetes, cardiovascular outcomes, major adverse cardiovascular events, lixisenatide, liraglutide, semaglutide, exenatide, dulaglutide, albiglutide, blood glucose reduction, weight loss, blood pressure, LDL cholesterol, low-grade inflammation, endothelial dysfunction, vasodilation, sodium excretion
Open Access status: closed
OpenAlex ID: W2885624998
